Home > Compound List > Compound details
60-40-2 molecular structure
click picture or here to close

N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine

ChemBase ID: 539
Molecular Formular: C11H21N
Molecular Mass: 167.29114
Monoisotopic Mass: 167.16739968
SMILES and InChIs

SMILES:
N(C1(C(C2CC1CC2)(C)C)C)C
Canonical SMILES:
CNC1(C)C2CCC(C1(C)C)C2
InChI:
InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3
InChIKey:
IMYZQPCYWPFTAG-UHFFFAOYSA-N

Cite this record

CBID:539 http://www.chembase.cn/molecule-539.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine
IUPAC Traditional name
mecamylaminum
Brand Name
Inversine
Inversine hydrochloride
Mecamine
Mecamine hydrochloride
Mekamin hydrochloride
Mekamine
Mevasin hydrochloride
Mevasine
Revertina
Versamine
Synonyms
2-Methylamino-2,3,3-trimethylnorbornane
2-Methylaminoisocamphane
3-Methylaminoisocamphane
3-Methylaminoisocamphane hydrochloride
Mecamylamine Hydrochloride
Mecamilamina
Mecamylamine
CAS Number
60-40-2
PubChem SID
46508607
160964002
PubChem CID
4032

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
DrugBank DB00657 external link
PubChem 4032 external link
Data Source Data ID Price

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
H Acceptors H Donor
LogD (pH = 5.5) -0.865205  LogD (pH = 7.4) -0.6689106 
Log P 2.3736398  Molar Refractivity 51.8325 cm3
Polarizability 21.091114 Å3 Polar Surface Area 12.03 Å2
Rotatable Bonds Lipinski's Rule of Five true 
Log P 3.13  LOG S -3.13 
Solubility (Water) 1.24e-01 g/l 

PROPERTIES

PROPERTIES

Physical Property Bioassay(PubChem)
Hydrophobicity(logP)
2.7 expand Show data source

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB00657 external link
Item Information
Drug Groups approved
Description A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. [PubChem]
Indication For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension
Pharmacology Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small oral dosage often produces a smooth and predictable reduction of blood pressure. Although this antihypertensive effect is predominantly orthostatic, the supine blood pressure is also significantly reduced. Mecamylamine crosses the blood-brain and placental barriers.
Affected Organisms
Humans and other mammals
Absorption Mecamylamine is almost completely absorbed from the gastrointestinal tract
Protein Binding 40%
Elimination Mecamylamine is excreted slowly in the urine in the unchanged form. The rate of its renal elimination is influenced markedly by urinary pH.
Alkalinization of the urine reduces, and acidification promotes, renal excretion of mecamylamine. Mecamylamine crosses the blood-brain and placental barriers.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle